Amphastar Pharmaceuticals(AMPH) - 2024 Q2 - Quarterly Results

EXHIBIT 99.1 Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2024 Reports Net Revenues of $182.4 Million for the Three Months Ended June 30, 2024 RANCHO CUCAMONGA, CA – August 7, 2024 – Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) ("Amphastar" or the "Company") today reported results for the three months ended June 30, 2024. Second Quarter Highlights ● Net revenues of $182.4 million for the second quarter ● GAAP net income of $37.9 million, or $0.73 per share, for t ...